Kirkland & Ellis counseled Warburg Pincus, a leading global growth investor, in its strategic investment in Global Healthcare Exchange (GHX), operator of the industry’s largest cloud-based trading network that connects those who buy, sell and use products needed to deliver patient care. As part of this transaction, minority investor Thoma Bravo has exited its investment. Existing investor Temasek, an investment company headquartered in Singapore, will remain the majority equity holder, and both Temasek and GHX are supportive of the investment by Warburg Pincus. The terms of the transaction were not disclosed.
Read Warburg Pincus’ press release
The Kirkland team was led by corporate partners Adam Larson and Allan Kirk and associates Patrick Moneypenny and Ryan McNulty.